Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
Phase 1
Completed
- Conditions
- Lymphoma, Marginal ZoneLymphoma, Mantle-CellLymphoma, FollicularLymphomaLymphoma, Large B-Cell, DiffuseLymphoma, B-CellLymphoma, Non-Hodgkin
- Interventions
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2022-05-19
- Lead Sponsor
- Triphase Research and Development III Corp.
- Target Recruit Count
- 32
- Registration Number
- NCT03682796
- Locations
- 🇺🇸
Banner MD Anderson, Gilbert, Arizona, United States
🇺🇸Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
🇺🇸Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
News
No news found